JPRN-jRCT2080220189未知3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phase
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
入选标准
- •Patients with Crohn's disease in active phase who are defined to show CDAI of 150 or higher but less than 250, and whose lesion is mainly observed at the end of ileum or lower part.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phasePatients with ulcerative colitis in remission phase.JPRN-C000000289Zeria Pharmaceutical Co.,LTD.120
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phasePatients with ulcerative colitis in active phaseJPRN-jRCT2080220176ZERIA Pharmaceutical Co.,Ltd.
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phasePatients with ulcerative colitis in active phaseJPRN-C000000288Zeria Pharmaceutical Co.,LTD.210
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phasePatients with ulcerative colitis in remission phaseJPRN-jRCT2080220177ZERIA Pharmaceutical Co.,Ltd.